Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Cortice Biosciences, Inc.
The primary objective of this study is to determine the maximum tolerated dose of TPI 287 for phase II clinical trials. The secondary objectives of the study are: * To determine the safety of TPI 287 * To determine antitumor activity of TPI 287 * To determine the pharmacokinetic profile of TPI 287 * To determine the pharmacodynamic profile of TPI 287
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted